![]() |
首頁 > 美迪醫(yī)訊 > 美研究如何降低因肺炎而住院治療的比例 |
美研究如何降低因肺炎而住院治療的比例 【?2006-01-09 發(fā)布?】 美迪醫(yī)訊
這是由匹茲堡大學醫(yī)學院(Pittsburgh , PA, USA)和匹茲堡VA醫(yī)療保健系統(tǒng)開展的一項研究的結(jié)果。這些研究結(jié)果發(fā)表在2005年12月的《內(nèi)科學年報》。 這項研究設計了32家醫(yī)院急診科的3,200多例診斷為肺炎的患者,這些患者由于肺炎而出現(xiàn)了各種不良預后的危險。所有參見研究的急診科同意遵循統(tǒng)一的治療指南,該指南是根據(jù)美國肺炎治療專家的意見而制定的。 這些急診科被隨機分配為低強度、中等強度或者高強度機構(gòu),--這些名稱反應了各家急診科采取的反饋、加強和持續(xù)的質(zhì)量提高的水平和強度。 據(jù)估計僅僅在美國每年大約有5百萬例患者被診斷為肺炎,但是盡管這種疾病發(fā)病率較高,醫(yī)生經(jīng)常高估了患者的死亡率,從而導致不必要而且費用昂貴的住院治療。 Reducing Pneumonia Hospitalizations These were the conclusions of a study conducted by investigators from the University of Pittsburgh School of Medicine (Pittsburgh , PA, USA) and the Pittsburgh VA Healthcare System. The findings were published in the December 2005 issue of the Annals of Internal Medicine. The study involved 32 hospital emergency departments and more than 3,200 patients diagnosed with pneumonia who posed varying risks of adverse outcomes from the disease. All participating emergency departments agreed to follow uniform practice guidelines, which were based on expert consensus of U.S. experts in pneumonia care. The emergency departments were randomly assigned as low-intensity, moderate-intensity or high-intensity sites--designations reflecting the level and intensity of feedback, reinforcement, and continuous quality improvement activities that each emergency department would carry out relevant to its pneumonia patients. An estimated 5 million pneumonia cases are diagnosed each year in the United States alone, but despite its prevalence, physicians frequently overestimate the probability of death in many pneumonia patients, leading to potentially unnecessary and costly hospitalizations. 本文關鍵字:
肺炎
《美迪醫(yī)訊》歡迎您參與新聞投稿,業(yè)務咨詢: 美迪醫(yī)療網(wǎng)業(yè)務咨詢更多關于 肺炎 的新聞
《上海醫(yī)療器械批發(fā)》產(chǎn)品推薦
|
合作支持:中華醫(yī)學會 | 中華醫(yī)院管理學會 | 國家食品藥品監(jiān)督管理家用護理器械商城 | 國藥勵展展覽有限責任公 | 醫(yī)學裝備協(xié)會 |
刊登廣告 | 友情鏈接 | 廣告代理商加盟 | 關于美迪 | 法律聲明 | 隱私保護 | 網(wǎng)站地圖 |
把美迪網(wǎng)放進收藏夾 把美迪醫(yī)療網(wǎng)介紹給我的朋友 給美迪醫(yī)療網(wǎng)留言
美迪醫(yī)療網(wǎng)廣告業(yè)務聯(lián)系:021-51601230 產(chǎn)品咨詢業(yè)務聯(lián)系:021-51601230 傳真:021-56532303 ![]() 互聯(lián)網(wǎng)藥品信息服務許可證:(滬)-經(jīng)營性-2009-0003 中華人民共和國電信與信息服務業(yè)務經(jīng)營許可證:(滬)B2-20090029 ![]() ![]() ![]() 公安備案號 31010602000199 醫(yī)療器械經(jīng)營許可證: 滬靜藥監(jiān)械經(jīng)營許20210003號 第二類醫(yī)療器械經(jīng)營備案憑證: 滬靜藥監(jiān)械經(jīng)營備20220042號 營業(yè)執(zhí)照:統(tǒng)一社會信用代碼91310108676284138X互聯(lián)網(wǎng)藥品信息服務資格書:(滬)-非經(jīng)營性-2023-0081 |